Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2015
At a glance
- Drugs INNO 305 (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 26 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Sep 2014 Planned End Date changed from 1 Jan 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov record.